Logo

ArcherDx

M&A Deals in MDx/Omics Research Tools Space Fall 13 Percent in 2020
Premium

Although the total number of deals went down in 2020, those deals were worth more compared to 2019 — four of the top five had billion-dollar price tags.

Invitae Q3 Revenues Increase 22 Percent

The firm generated $68.7 million in revenues compared to $56.5 million in Q3 2019 and exceeded the consensus Wall Street estimate. 

Natera Sues Genosity for Patent Infringement Relating to ArcherDx Products

Natera claims that several Genosity products infringe its US Patent No. 10,732,220, titled "Methods for Simultaneous Amplification of Target Loci."

Federal Court Rejects ArcherDx Motion Against Natera in Patent Infringement Lawsuit

Last month, the court also ordered two separate patent lawsuits filed by Natera against ArcherDx this year to be consolidated into one.

Invitae Completes Acquisition of ArcherDx

The merger brings tumor profiling and liquid biopsy technologies for predicting and monitoring therapeutic response to Invitae's service offerings.

Aug 7, 2020

Natera Files Additional Patent Infringement Lawsuit Against ArcherDx

Jul 1, 2020

Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index

Jun 22, 2020

Invitae, ArcherDx Ink $1.4B Merger to Advance Precision Oncology Offerings

Jun 18, 2020

ArcherDx, Bristol Myers Squibb Partner on Minimal Residual Disease Monitoring

Jun 7, 2020

ArcherDx Targeting $100M in IPO

May 26, 2020

AstraZeneca, ArcherDx Partner on Minimal Residual Disease Monitoring for Lung Cancer Drug Trials

May 14, 2020

ArcherDx, Bayer Partner on NGS-Based Companion Diagnostic Test Development

Apr 21, 2020

ArcherDx, Premier Collaborate to Evaluate Genomic Sequencing Assay for Cancers

Apr 15, 2020

Natera Expands IP Lawsuit Against ArcherDx With Three New Patents

Mar 25, 2020

Japanese Regulators Approve Merck KGaA MET Inhibitor With ArcherDx CDx

Jan 27, 2020

Natera Sues ArcherDx for Infringement of New Target Amplification Patent

Jan 10, 2020

ArcherDx, Illumina Agree to Comarket Future IVDs

Dec 17, 2019

ArcherDx Closes $55M Series C Financing

Dec 3, 2019

Illumina, ArcherDx Expand Partnership on NGS IVD Tests

Jul 8, 2019

Ayala, ArcherDx Partner to Advance CDx for Notch Inhibitors

May 24, 2019

Multi-Site Study Tests Power of Commercial Reference Materials in Comparing Liquid Biopsy Assays
Premium

May 15, 2019

ArcherDx Raises $60M in Series B Financing Round

Apr 2, 2019

Combined Analysis of DNA, RNA Gaining Popularity in Pediatric Cancer Research

Feb 12, 2019

ArcherDx to Comarket Genosity Consulting, Lab Software Services

Jan 30, 2019

ArcherDx Acquires Baby Genes

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.